Evidence map›Paper›PMID 32104466›Full record

ReviewAsian journal of pharmaceutical sciences2019

Current developments in drug delivery with thermosensitive liposomes.

Hongshu Bi, Jianxiu Xue, Hong Jiang, Shan Gao, Dongjuan Yang, Yan Fang, Kai Shi

Open access · diamondAbstract readReview
In one paragraph

Review in Asian journal of pharmaceutical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Effective Use ofCurrent issues in molecular biology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Volumetric hyperthermia delivery using the ExAblate Body MR-guided focused ultrasound system.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hongshu BiInstitute of New Drug Development, Liaoning Yaolian Pharmaceutical Co., Ltd., Benxi, Liaoning 117004, China.
Jianxiu XueSchool of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning 117004, China.
Hong JiangSchool of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning 117004, China.
Shan GaoSchool of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning 117004, China.
Dongjuan YangSchool of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning 117004, China.
Yan FangSchool of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning 117004, China.
Kai ShiSchool of Pharmacy, Shenyang Pharmaceutical University, Benxi, Liaoning 117004, China.
Shenyang Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thermosensitive liposomes (TSLs) have been an important research area in the field of tumor targeted chemotherapy. Since the first TSLs appeared that using 1,2-dipalmitoyl-sn-glyce-ro-3-phosphocholine (DPPC) as the primary liposomal lipid, many studies have been done using this type of liposome from basic and practical aspects. While TSLs composed of DPPC enhance the cargo release near the phase transition temperature, it has been shown that many factors affect their temperature sensitivity. Thus numerous attempts have been undertaken to develop new TSLs for improving their thermal response performance. The main objective of this review is to introduce the development and recent update of innovative TSLs formulations, including combination of radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), magnetic resonance imaging (MRI) and alternating magnetic field (AMF). In addition, various factors affecting the design of TSLs, such as lipid composition, surfactant, size and serum components are also discussed.

Indexed as

Content release rate(DPPC), 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine(DPPGOG), 1,2-dipalmitoyl-sn-glycero-3-phosphoglyceroglycerolDrug delivery(DSPC), 1,2-distearoyl-sn-glycero-3-phosphocholine(DSPE-mPEG2000), 1,2-distearoyl-sn-glycero-3-phosphatiylethanol-amine-N-[methoxy(polyethyleneglycol)-2000]fTSLs, fast release TSLsHyperthermia(LTSLs), lyso-lipid temperature sensitive liposomes(MPPC), 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphatidylcholine(MSPC), 1-stearoyl-2-hydroxy-sn-glycero-3-phosphatidylcholine(P188), 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphatidylcholinex(P188), HO-(C2H4O)a-(C3H6O)b-(C2H4O)c-H, a=80, b=27, c=80(P-lyso-PC), lysophosphatidylcholineSmart liposomessTSLs, slow release TSLsThermosensitive liposomesTumor chemotherapy

Identifiers

PMID32104466
PMCPMC7032122
OpenAlexW2898883627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.